- Home
- ITT vs EXEL Comparison
ITT vs EXEL Comparison
Compare ITT & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITT
- EXEL
- Stock Information
- Founded
- ITT 1920
- EXEL 1994
- Country
- ITT United States
- EXEL United States
- Employees
- ITT N/A
- EXEL N/A
- Industry
- ITT Fluid Controls
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITT Industrials
- EXEL Health Care
- Exchange
- ITT Nasdaq
- EXEL Nasdaq
- Market Cap
- ITT 11.8B
- EXEL 11.6B
- IPO Year
- ITT N/A
- EXEL 2000
- Fundamental
- Price
- ITT $149.20
- EXEL $40.62
- Analyst Decision
- ITT Strong Buy
- EXEL Buy
- Analyst Count
- ITT 9
- EXEL 18
- Target Price
- ITT $165.50
- EXEL $39.59
- AVG Volume (30 Days)
- ITT 377.1K
- EXEL 2.7M
- Earning Date
- ITT 07-31-2025
- EXEL 08-05-2025
- Dividend Yield
- ITT 0.93%
- EXEL N/A
- EPS Growth
- ITT 22.94
- EXEL 237.58
- EPS
- ITT 6.28
- EXEL 2.20
- Revenue
- ITT $3,633,100,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- ITT $5.13
- EXEL $9.37
- Revenue Next Year
- ITT $4.64
- EXEL $11.05
- P/E Ratio
- ITT $23.98
- EXEL $18.49
- Revenue Growth
- ITT 6.99
- EXEL 24.49
- 52 Week Low
- ITT $105.64
- EXEL $21.36
- 52 Week High
- ITT $161.13
- EXEL $48.85
- Technical
- Relative Strength Index (RSI)
- ITT 55.19
- EXEL 44.39
- Support Level
- ITT $149.26
- EXEL $41.03
- Resistance Level
- ITT $153.66
- EXEL $42.07
- Average True Range (ATR)
- ITT 2.10
- EXEL 0.90
- MACD
- ITT -0.65
- EXEL -0.40
- Stochastic Oscillator
- ITT 50.58
- EXEL 3.56
About ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.